Merit Medical Systems Analyst Ratings
Merit Medical Systems Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/16/2023 | 38.67% | Barrington Research | → $95 | Reiterates | Outperform → Outperform |
07/26/2023 | 40.13% | Needham | → $96 | Reiterates | Buy → Buy |
07/21/2023 | 34.29% | Piper Sandler | $85 → $92 | Maintains | Overweight |
07/06/2023 | 38.67% | Barrington Research | → $95 | Reiterates | Outperform → Outperform |
06/09/2023 | 38.67% | Barrington Research | $90 → $95 | Maintains | Outperform |
06/09/2023 | 40.13% | Needham | $90 → $96 | Maintains | Buy |
05/08/2023 | 35.75% | Raymond James | $88 → $93 | Maintains | Outperform |
04/27/2023 | 24.07% | Piper Sandler | $77 → $85 | Maintains | Overweight |
04/27/2023 | 31.37% | Barrington Research | $78 → $90 | Maintains | Outperform |
04/27/2023 | 18.23% | Wells Fargo | $74 → $81 | Maintains | Equal-Weight |
04/27/2023 | 28.45% | Raymond James | $86 → $88 | Maintains | Outperform |
04/27/2023 | 31.37% | Needham | $84 → $90 | Maintains | Buy |
04/18/2023 | 22.61% | Needham | $78 → $84 | Maintains | Buy |
04/17/2023 | 25.53% | Raymond James | $80 → $86 | Maintains | Outperform |
04/12/2023 | 13.85% | Barrington Research | → $78 | Reiterates | → Outperform |
02/23/2023 | 13.85% | Barrington Research | → $78 | Reiterates | → Outperform |
02/23/2023 | 12.39% | Piper Sandler | $73 → $77 | Maintains | Overweight |
02/23/2023 | 16.77% | Raymond James | $72 → $80 | Maintains | Outperform |
02/23/2023 | 13.85% | Needham | $73 → $78 | Maintains | Buy |
12/20/2022 | 5.09% | Canaccord Genuity | → $72 | Downgrades | Buy → Hold |
10/27/2022 | 5.09% | Raymond James | $71 → $72 | Maintains | Outperform |
10/14/2022 | -8.04% | Canaccord Genuity | $69 → $63 | Maintains | Buy |
09/02/2022 | 0.72% | Canaccord Genuity | $67 → $69 | Maintains | Buy |
07/28/2022 | 3.63% | Raymond James | $72 → $71 | Maintains | Outperform |
02/25/2022 | 5.09% | Raymond James | $73 → $72 | Maintains | Outperform |
02/25/2022 | 6.55% | Needham | $83 → $73 | Maintains | Buy |
10/29/2021 | 8.01% | Wells Fargo | $68 → $74 | Maintains | Equal-Weight |
07/30/2021 | 6.55% | Raymond James | $69 → $73 | Maintains | Outperform |
07/30/2021 | -0.74% | Wells Fargo | $65 → $68 | Maintains | Equal-Weight |
07/30/2021 | 21.15% | Needham | $73 → $83 | Maintains | Buy |
04/30/2021 | 6.55% | Needham | $68 → $73 | Maintains | Buy |
04/30/2021 | 0.72% | Raymond James | $61 → $69 | Maintains | Outperform |
02/25/2021 | -10.96% | Raymond James | $60 → $61 | Maintains | Outperform |
02/25/2021 | -0.74% | Needham | $65 → $68 | Maintains | Buy |
01/05/2021 | -5.12% | Needham | → $65 | Upgrades | Hold → Buy |
11/11/2020 | -12.42% | Raymond James | $57 → $60 | Maintains | Outperform |
10/29/2020 | 5.09% | Sidoti & Co. | $63 → $72 | Maintains | Buy |
10/29/2020 | -25.56% | Wells Fargo | $42 → $51 | Maintains | Equal-Weight |
10/29/2020 | -9.5% | Piper Sandler | $55 → $62 | Maintains | Overweight |
10/29/2020 | -16.8% | Raymond James | $51 → $57 | Maintains | Outperform |
10/29/2020 | -19.72% | Canaccord Genuity | $51 → $55 | Maintains | Buy |
09/28/2020 | -38.7% | Wells Fargo | → $42 | Upgrades | Underweight → Equal-Weight |
07/30/2020 | -19.72% | Piper Sandler | $50 → $55 | Maintains | Overweight |
07/30/2020 | -27.02% | Oppenheimer | $46 → $50 | Maintains | Outperform |
07/30/2020 | -25.56% | Raymond James | $49 → $51 | Maintains | Outperform |
06/01/2020 | -8.04% | Sidoti & Co. | $55 → $63 | Maintains | Buy |
05/27/2020 | -28.48% | Raymond James | $46 → $49 | Maintains | Outperform |
04/24/2020 | -32.86% | Raymond James | $44 → $46 | Maintains | Outperform |
04/24/2020 | -45.99% | Wells Fargo | $33 → $37 | Maintains | Underweight |
02/25/2020 | -27.02% | Piper Sandler | $42 → $50 | Reiterates | → Overweight |
02/25/2020 | -51.83% | Wells Fargo | $26 → $33 | Maintains | Underweight |
02/25/2020 | -31.4% | Raymond James | $43 → $47 | Maintains | Outperform |
02/03/2020 | -37.24% | Raymond James | → $43 | Upgrades | Market Perform → Outperform |
12/12/2019 | — | Wells Fargo | Downgrades | Equal-Weight → Underweight | |
10/31/2019 | -56.21% | Piper Sandler | $40 → $30 | Maintains | Overweight |
10/31/2019 | -19.72% | Sidoti & Co. | $74 → $55 | Maintains | Buy |
10/31/2019 | -56.21% | B of A Securities | $37 → $30 | Maintains | Underperform |
09/24/2019 | -41.61% | Oppenheimer | → $40 | Initiates Coverage On | → Outperform |
09/20/2019 | -45.99% | Canaccord Genuity | $53 → $37 | Maintains | Buy |
09/17/2019 | -41.61% | Piper Sandler | $58 → $40 | Maintains | Overweight |
09/10/2019 | — | Raymond James | Downgrades | Outperform → Market Perform | |
07/26/2019 | — | Needham | Downgrades | Buy → Hold | |
07/26/2019 | -22.64% | Canaccord Genuity | $63 → $53 | Maintains | Buy |
07/26/2019 | — | Wells Fargo | Downgrades | Outperform → Market Perform | |
10/26/2018 | 5.09% | Canaccord Genuity | $70 → $72 | Maintains | Buy |
日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
---|---|---|---|---|---|
08/16/2023 | 38.67% | 巴靈頓研究公司 | →$95 | 重申 | 跑贏→跑贏大盤 |
07/26/2023 | 40.13% | 李約瑟 | →$96 | 重申 | 購買→購買 |
07/21/2023 | 34.29% | 派珀·桑德勒 | $85→$92 | 維護 | 超重 |
07/06/2023 | 38.67% | 巴靈頓研究公司 | →$95 | 重申 | 跑贏→跑贏大盤 |
06/09/2023 | 38.67% | 巴靈頓研究公司 | $90→$95 | 維護 | 跑贏大盤 |
06/09/2023 | 40.13% | 李約瑟 | $90→$96 | 維護 | 買 |
05/08/2023 | 35.75% | 雷蒙德·詹姆斯 | $88→$93 | 維護 | 跑贏大盤 |
04/27/2023 | 24.07% | 派珀·桑德勒 | $77→$85 | 維護 | 超重 |
04/27/2023 | 31.37% | 巴靈頓研究公司 | $78→$90 | 維護 | 跑贏大盤 |
04/27/2023 | 18.23% | 富國銀行 | $74→$81 | 維護 | 等重 |
04/27/2023 | 28.45% | 雷蒙德·詹姆斯 | $86→$88 | 維護 | 跑贏大盤 |
04/27/2023 | 31.37% | 李約瑟 | $84→$90 | 維護 | 買 |
04/18/2023 | 22.61% | 李約瑟 | $78→$84 | 維護 | 買 |
04/17/2023 | 25.53% | 雷蒙德·詹姆斯 | $80→$86 | 維護 | 跑贏大盤 |
04/12/2023 | 13.85% | 巴靈頓研究公司 | →$78 | 重申 | →跑贏大盤 |
02/23/2023 | 13.85% | 巴靈頓研究公司 | →$78 | 重申 | →跑贏大盤 |
02/23/2023 | 12.39% | 派珀·桑德勒 | $73→$77 | 維護 | 超重 |
02/23/2023 | 16.77% | 雷蒙德·詹姆斯 | $72→$80 | 維護 | 跑贏大盤 |
02/23/2023 | 13.85% | 李約瑟 | $73→$78 | 維護 | 買 |
12/20/2022 | 5.09% | 卡納科特·格納奇 | →$72 | 評級下調 | 購買→Hold |
10/27/2022 | 5.09% | 雷蒙德·詹姆斯 | $71→$72 | 維護 | 跑贏大盤 |
10/14/2022 | -8.04% | 卡納科特·格納奇 | $69→$63 | 維護 | 買 |
09/02/2022 | 0.72% | 卡納科特·格納奇 | $67→$69 | 維護 | 買 |
07/28/2022 | 3.63% | 雷蒙德·詹姆斯 | $72→$71 | 維護 | 跑贏大盤 |
02/25/2022 | 5.09% | 雷蒙德·詹姆斯 | $73→$72 | 維護 | 跑贏大盤 |
02/25/2022 | 6.55% | 李約瑟 | $83→$73 | 維護 | 買 |
10/29/2021 | 8.01% | 富國銀行 | $68→$74 | 維護 | 等重 |
07/30/2021 | 6.55% | 雷蒙德·詹姆斯 | $69→$73 | 維護 | 跑贏大盤 |
07/30/2021 | -0.74% | 富國銀行 | $65→$68 | 維護 | 等重 |
07/30/2021 | 21.15% | 李約瑟 | $73→$83 | 維護 | 買 |
04/30/2021 | 6.55% | 李約瑟 | $68→$73 | 維護 | 買 |
04/30/2021 | 0.72% | 雷蒙德·詹姆斯 | $61→$69 | 維護 | 跑贏大盤 |
02/25/2021 | -10.96% | 雷蒙德·詹姆斯 | $60→$61 | 維護 | 跑贏大盤 |
02/25/2021 | -0.74% | 李約瑟 | $65→$68 | 維護 | 買 |
01/05/2021 | -5.12% | 李約瑟 | →$65 | 升級 | 持有→購買 |
11/11/2020 | -12.42% | 雷蒙德·詹姆斯 | $57→$60 | 維護 | 跑贏大盤 |
10/29/2020 | 5.09% | 西多蒂公司 | $63→$72 | 維護 | 買 |
10/29/2020 | -25.56% | 富國銀行 | $42→$51 | 維護 | 等重 |
10/29/2020 | -9.5% | 派珀·桑德勒 | $55→$62 | 維護 | 超重 |
10/29/2020 | -16.8% | 雷蒙德·詹姆斯 | $51→$57 | 維護 | 跑贏大盤 |
10/29/2020 | -19.72% | 卡納科特·格納奇 | $51→$55 | 維護 | 買 |
09/28/2020 | -38.7% | 富國銀行 | →$42 | 升級 | 重量不足的→等重 |
07/30/2020 | -19.72% | 派珀·桑德勒 | $50→$55 | 維護 | 超重 |
07/30/2020 | -27.02% | 奧本海默 | $46→$50 | 維護 | 跑贏大盤 |
07/30/2020 | -25.56% | 雷蒙德·詹姆斯 | $49→$51 | 維護 | 跑贏大盤 |
06/01/2020 | -8.04% | 西多蒂公司 | $55→$63 | 維護 | 買 |
05/27/2020 | -28.48% | 雷蒙德·詹姆斯 | $46→$49 | 維護 | 跑贏大盤 |
04/24/2020 | -32.86% | 雷蒙德·詹姆斯 | $44→$46 | 維護 | 跑贏大盤 |
04/24/2020 | -45.99% | 富國銀行 | $33→$37 | 維護 | 體重不足 |
02/25/2020 | -27.02% | 派珀·桑德勒 | $42→$50 | 重申 | →超重 |
02/25/2020 | -51.83% | 富國銀行 | $26→$33 | 維護 | 體重不足 |
02/25/2020 | -31.4% | 雷蒙德·詹姆斯 | $43→$47 | 維護 | 跑贏大盤 |
02/03/2020 | -37.24% | 雷蒙德·詹姆斯 | →$43 | 升級 | 市場表現優於→ |
2019年12月12日 | - | 富國銀行 | 評級下調 | 等重→減碼 | |
2019年10月31日 | -56.21% | 派珀·桑德勒 | $40→$30 | 維護 | 超重 |
2019年10月31日 | -19.72% | 西多蒂公司 | $74→$55 | 維護 | 買 |
2019年10月31日 | -56.21% | B of A證券 | $37→$30 | 維護 | 表現不佳 |
2019年09月24日 | -41.61% | 奧本海默 | →$40 | 開始承保 | →跑贏大盤 |
2019年09月20日 | -45.99% | 卡納科特·格納奇 | $53→$37 | 維護 | 買 |
2019/09/17 | -41.61% | 派珀·桑德勒 | $58→$40 | 維護 | 超重 |
2019年09月10日 | - | 雷蒙德·詹姆斯 | 評級下調 | 跑贏→市場表現 | |
2019年07月26日 | - | 李約瑟 | 評級下調 | 購買→Hold | |
2019年07月26日 | -22.64% | 卡納科特·格納奇 | $63→$53 | 維護 | 買 |
2019年07月26日 | - | 富國銀行 | 評級下調 | 跑贏→市場表現 | |
2018年10月26日 | 5.09% | 卡納科特·格納奇 | $70→$72 | 維護 | 買 |
What is the target price for Merit Medical Systems (MMSI)?
Merit Medical Systems(MMSI)的目標價格是多少?
The latest price target for Merit Medical Systems (NASDAQ: MMSI) was reported by Barrington Research on August 16, 2023. The analyst firm set a price target for $95.00 expecting MMSI to rise to within 12 months (a possible 38.67% upside). 23 analyst firms have reported ratings in the last year.
巴靈頓研究公司於2023年8月16日報道了Merit醫療系統公司(納斯達克代碼:MMSI)的最新目標價。這家分析公司將目標價定為95.00美元,預計MMSI將在12個月內上漲至38.67%。過去一年,23家分析公司公佈了評級。
What is the most recent analyst rating for Merit Medical Systems (MMSI)?
最新分析師對Merit Medical Systems(MMSI)的評級是多少?
The latest analyst rating for Merit Medical Systems (NASDAQ: MMSI) was provided by Barrington Research, and Merit Medical Systems reiterated their outperform rating.
巴靈頓研究公司提供了對默裡特醫療系統公司(納斯達克代碼:MMSI)的最新分析師評級,默裡特醫療系統公司重申了其表現優於大盤的評級。
When is the next analyst rating going to be posted or updated for Merit Medical Systems (MMSI)?
Merit Medical Systems(MMSI)的下一次分析師評級將於何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Merit Medical Systems, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Merit Medical Systems was filed on August 16, 2023 so you should expect the next rating to be made available sometime around August 16, 2024.
分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與Merit Medical Systems的高管和客戶交談,以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Merit Medical Systems的上一次評級是在2023年8月16日提交的,因此您應該預計下一次評級將在2024年8月16日左右提供。
Is the Analyst Rating Merit Medical Systems (MMSI) correct?
分析師對Merit Medical Systems(MMSI)的評級正確嗎?
While ratings are subjective and will change, the latest Merit Medical Systems (MMSI) rating was a reiterated with a price target of $0.00 to $95.00. The current price Merit Medical Systems (MMSI) is trading at is $68.51, which is within the analyst's predicted range.
雖然評級是主觀的,並將發生變化,但最新的Merit Medical Systems(MMSI)評級被重申,目標價在0.00美元至95.00美元之間。Merit Medical Systems(MMSI)目前的交易價格為68.51美元,在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。